26 Marzo 2025

Sono disponibili da oggi le slide di presentazioni e interventi dei partecipanti all'undicesima edizione del Meeting Internazionale PULMONARY RARE DISEASES AND ORPHAN DRUGS, che si è a tenuto a Milano, al Centro Congressi Fondazione Cariplo, il 14 e 15 Marzo 2025.

Buona lettura!
I Presidenti SERGIO HARARI e MARC HUMBERT

For more information visit: WWW.PULMONARYRAREDISEASES.COM

Venerdì 14 marzo 2025

Pulmonary Hypertension: key learnings from the 7th World Symposium

Pulmonary Hypertension: diagnostic and classification | Laura Price (London, UK)
1.32 MB

Novel imaging modalities in pulmonary vascular diseases | Olivier Meyrignac (Paris, France)
5.14 MB

CTEPH: the era of multimodality management | Gérald Simonneau (Paris, France)
1.35 MB

PAH: treatment algorithm | Olivier Sitbon (Paris, France)
6.2 MB

New therapeutic approaches to PAH | Marc Humbert (Paris, France)
4.78 MB

Pulmonary Hypertension associated with cardio-pulmonary diseases

Group 2 PH | Jean Luc Vachiéry (Brussels, Belgium)
1.94 MB

Group 3 PH | Oksana Shlobin (Falls Chruch, VA – USA)
3.22 MB

Sleep breathing disorders in PH | Yochai Adir (Haifa, Israel)
581.57 KB

Group 1 PAH with cardiopulmonary comorbidities | Athénaïs Boucly (Paris, France)
3.46 MB

The left heart in ILD | Sergio Harari (Milan, Italy)
1.45 MB

Oral presentation session

Characterising patients with pulmonary langerhans’ cell histiocytosis and pulmonary hypertension | Maria Kokosi (UK)
906.23 KB

Cystic lung in sarcoidosis: clinico-radiological characteristic and evolution | Giovanni Franco (Italy)
1.5 MB

Retrospective evaluation of the reduction or discontinuation of pulmonary hypertension medical treatment after pulmonary angioplasties in inoperable CTEPH | Sabina Solinas (France)
322.74 KB

Ten-year follow-up of monozygotic twin sisters with TSC-LAM: a rare case report | Lu Fan (China – Italy)
1.14 MB

Deep-learning analysis of pulmonary vascular volume: prognostic implications in Idiopathic Pulmonary Fibrosis | Annalisa Mazzocca (Italy)
1.96 MB

IPF and around

Biological and radiological phenotyping | Bruno Crestani (Paris, France)
3.75 MB

PPF is IPF: it is true? | Philip Molyneaux (London, UK)
3.91 MB

Sabato 15 marzo 2025

Not only IPF

The lung in RA | Katerina Antoniou (Heraklion, Greece)
7.69 MB

ANCA and idiopathic interstitial pneumonia | Antonella Caminati (Milan, Italy)
3.08 MB

Scleroderma-related ILD. What’s new? | Roberto Caporali (Milan, Italy)
3.68 MB

Hypersensitivity pneumonitis: one or more diseases? | Maria Molina Molina (Barcelona, Spain)
4.84 MB

New treatment approaches to Sarcoidosis | Elena Bargagli (Siena, Italy)
4.85 MB

IgG4 disease. What is it? | Emanuel Della Torre (Milan, Italy)
3.9 MB

Novel imaging modalities in parenchymal lung disease | Roberta E. Ledda (Parma, Italy)
2.09 MB

Drug development in rare and ultra rare diseases | Not only rare diseases

LAM | Davide Elia (Milan, Italy)
1.57 MB

Cystic fibrosis in adult: new approaches | Isabelle Fajac (Paris, France)
2.63 MB

Do we still need to phenotype severe asthma? | Klaus Rabe (Hamburg, Germany)
3.89 MB

COPD and treatable traits | Leonardo Fabbri (Modena, Italy)
4.38 MB

Mesothelioma | Joanna Chorostowska (Warsaw, Poland)
1.5 MB

Ti consigliamo anche

Archivio eventi

11th International Meeting on PULMONARY RARE DISEASES AND ORPHAN DRUGS

Archivio eventi

10° Congresso internazionale - Meeting on Pulmonary Rare Diseases and Orphan Drugs

COVID-19 e Vaccini

Covid il pericolo di dimenticare

Salute e società

La sanità è da ripensare